• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于吸入式肺部成像的锝气体

Technegas for inhalation lung imaging.

作者信息

Isawa T, Teshima T, Anazawa Y, Miki M, Motomiya M

机构信息

Department of Medicine, Tohoku University, Sendai, Japan.

出版信息

Nucl Med Commun. 1991 Jan;12(1):47-55. doi: 10.1097/00006231-199101000-00006.

DOI:10.1097/00006231-199101000-00006
PMID:1850822
Abstract

Technegas, an aerosol generator recently devised in Australia, produces aerosol particulates called 'technegas' which have characteristics of both an aerosol and a gas. The majority of the particulate is below 200 nm in size as measured by electron microscopy. Four normal subjects and 31 patients with various lung diseases were studied by imaging the lungs following inhalation of technegas. The penetration of inhaled technegas to the lung periphery was excellent; the average alveolar deposition ratio (ALDR) was 85%. Comparative studies with lung images obtained either with an ultrasonic nebulizer or jet nebulizers also confirmed better penetration of inhaled technegas to the lung periphery. There was no significant statistical difference in the ALDRs between normals and patients. Aerosol studies were comparable to perfusion counterparts, and evaluation of regional ventilatory status was greatly facilitated. Because of the large ALDR and the low airway deposition ratio (ADR), actual imaging could be done not only immediately after aerosol inhalation but also some time later without losing too much radioactivity from the lungs. One disadvantage was that technegas immediately after generation was anoxic.

摘要

技术气体(Technegas)是澳大利亚最近研制的一种气溶胶发生器,它能产生一种名为“技术气体”的气溶胶颗粒,这种颗粒兼具气溶胶和气体的特性。通过电子显微镜测量,大部分颗粒的尺寸在200纳米以下。对4名正常受试者和31名患有各种肺部疾病的患者在吸入技术气体后进行肺部成像研究。吸入的技术气体向肺周边的渗透情况良好;平均肺泡沉积率(ALDR)为85%。与使用超声雾化器或喷射雾化器获得的肺部图像进行的对比研究也证实,吸入的技术气体向肺周边的渗透更好。正常人与患者之间的肺泡沉积率没有显著的统计学差异。气溶胶研究与灌注研究相当,极大地促进了对局部通气状态的评估。由于肺泡沉积率高且气道沉积率(ADR)低,不仅可以在气溶胶吸入后立即进行实际成像,而且在一段时间后也可以进行,而肺部不会损失太多放射性。一个缺点是,技术气体产生后立即处于缺氧状态。

相似文献

1
Technegas for inhalation lung imaging.用于吸入式肺部成像的锝气体
Nucl Med Commun. 1991 Jan;12(1):47-55. doi: 10.1097/00006231-199101000-00006.
2
[Radioaerosol inhalation lung imaging using technegas].
Kaku Igaku. 1990 Nov;27(11):1273-80.
3
[Kinetics and clinical application of 99mTc-technegas].[99mTc-锝气体的动力学及临床应用]
Kaku Igaku. 1990 Jul;27(7):725-33.
4
Technegas versus krypton-81m gas as an inhalation agent. Comparison of pulmonary distribution at total lung capacity.
Clin Nucl Med. 1994 Dec;19(12):1085-90. doi: 10.1097/00003072-199419120-00010.
5
[Inhalation scintigraphy of the lung using the new ultrafine aerosol Technegas].
Nuklearmedizin. 1989 Apr;28(2):113-20.
6
Inhalation of pertechnegas: similar clearance from the lungs to that of inhaled pertechnetate aerosol.
Nucl Med Commun. 1995 Sep;16(9):741-6.
7
Dynamics of 'Technegas' deposited in the lung.沉积在肺部的“锝气体”的动力学
Nucl Med Commun. 2001 Apr;22(4):383-7. doi: 10.1097/00006231-200104000-00006.
8
[Clinical evaluation of lung scintigraphy with 99mTc-technegas].
Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Dec 25;50(12):1590-600.
9
The use of 99Tcm-Technegas in the investigation of patients with pulmonary thromboembolism.99锝-聚合白蛋白微球在肺血栓栓塞症患者检查中的应用。
Nucl Med Commun. 1995 Oct;16(10):802-10. doi: 10.1097/00006231-199510000-00002.
10
Difference in inhaled aerosol deposition patterns in the lungs due to three different sized aerosols.三种不同大小的气雾剂导致的肺部吸入气雾剂沉积模式的差异。
Nucl Med Commun. 1992 Jul;13(7):553-62. doi: 10.1097/00006231-199207000-00012.

引用本文的文献

1
Ventilation Scintigraphy With Radiolabeled Carbon Nanoparticulate Aerosol (Technegas): State-of-the-Art Review and Diagnostic Applications to Pulmonary Embolism During COVID-19 Pandemic.放射性标记碳纳米颗粒气溶胶通气闪烁显像(Technegas):COVID-19 大流行期间用于肺栓塞的最新技术综述和诊断应用。
Clin Nucl Med. 2023 Jan 1;48(1):8-17. doi: 10.1097/RLU.0000000000004426. Epub 2022 Oct 26.
2
Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use.用于肺通气/灌注PET/CT成像的放射性药物标记:临床应用的生产与优化过程综述
Pharmaceuticals (Basel). 2022 Apr 22;15(5):518. doi: 10.3390/ph15050518.
3
Complementarity of lung scintigraphy and D-dimer test in pulmonary embolism.
肺灌注显像与D-二聚体检测在肺栓塞诊断中的互补性
Eur J Nucl Med. 1997 Apr;24(4):444-7. doi: 10.1007/BF00881819.
4
Evaluation of lung clearance of inhaled pertechnegas.
Ann Nucl Med. 1996 Feb;10(1):147-51. doi: 10.1007/BF03165070.
5
The influence of inhalation technique on Technegas particle deposition and image appearance in normal volunteers.
Eur J Nucl Med. 1994 May;21(5):394-8. doi: 10.1007/BF00171413.
6
Technegas: a study of particle structure, size and distribution.锝气体:颗粒结构、大小及分布的研究
Eur J Nucl Med. 1993 Jul;20(7):576-9. doi: 10.1007/BF00176550.
7
Technegas: particle size and distribution.锝气体:粒径与分布
Eur J Nucl Med. 1994 Apr;21(4):365-7. doi: 10.1007/BF00947975.
8
Technegas and Pertechnegas particle size distribution.
Eur J Nucl Med. 1995 May;22(5):473-6. doi: 10.1007/BF00839062.
9
Texture analysis of technegas lung ventilation images.
Med Biol Eng Comput. 1995 Jan;33(1):52-7. doi: 10.1007/BF02522946.
10
An evaluation of Technegas as a ventilation agent compared with krypton-81 m in the scintigraphic diagnosis of pulmonary embolism.与氪-81m相比,评估锝气体作为通气剂在肺栓塞闪烁显像诊断中的应用。
Eur J Nucl Med. 1992;19(9):770-4. doi: 10.1007/BF00182818.